Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NASH

Recent news which mentions NASH

IPO Outlook: Solar Power Company Array Technologies, Chinese Retailer Miniso Lead Possible 9 IPO Week
Tickers ARRY BX EAR IONS
Tags Market News Array Technologies Penny Stocks
From Benzinga
IPO Outlook For The Week: Snowflake and Amwell Lead Busy 12 IPO Lineup
Tickers AMZN BNL CRM GOOG
Tags Benzinga Epic Games TDOC
From Benzinga
Why Shares Of NASH Biotech Intercept Pharma Are Slumping
Tickers ICPT
Tags Market News Biotech FDA
From Benzinga
Diverging NASH Stories: CymaBay On Track To Restart, GenFit's Drug Flunks Late-Stage Study
Tickers CBAY GNFT
Tags Market News Top Stories Biotech
From Benzinga
NGM Biopharma Shares Spike Higher On Positive NASH Study Results
Tickers NGM
Tags Trading Ideas Movers News
From Benzinga
13 Key NASH Drug Candidates To Watch For In A Potential $30-Billion Market
Tickers AGN BMY ENTA GALT
Tags Biotech ENTA Trading Ideas
From Benzinga
ContraVir Moves Higher After NASH Drug Shows 100% Efficacy In Fibrosis Prevention
Tickers CTRV GNFT ICPT
Tags GNFT Benzinga ICPT
From Benzinga
ContraVir Rallies As NASH Drug Shows Efficacy In Preclinical Study
Tickers CTRV GILD ICPT
Tags Market News NASH Biotech
From Benzinga
Gilead Reiterates Faith In NASH Combination Approach After Another Trial Disappointment
Tickers GILD ICPT
Tags Market News Raymond James NASH
From Benzinga
Conatus Shares Fall By More Than 50% After Midstage Study Shows NASH Candidate Lagged Placebo
Tickers CNAT GILD ICPT NVS
Tags Market News CNAT NASH
From Benzinga
Intercept Shares Soar To Multimonth High After NASH Drug Aces Late-Stage Trial
Tickers GILD ICPT
Tags Market News NASH FDA
From Benzinga
Analyst: Intercept's NASH Drug Could Launch Sans Competition After Gilead Trial Failure
Tickers GILD ICPT
Tags GILD General ICPT
From Benzinga
Lipocine's NASH Candidate Shows Promise In Liver Fat Study
Tickers LPCN
Tags Biotech NASH Market News
From Benzinga
Raymond James Reviews Gilead Pipelines, Takes Bullish Stance On Pharma Stock
Tickers CART GILD NASH
Tags Benzinga Steven Seedhouse Initiation
From Benzinga
3 Key Retail Picks as Bed Bath & Beyond Tumbles
Tickers CDL CNDF DG FHD
Tags CDL Macys CNDF
From ETF Trends
Will Intercept Stock Potential Be Blindsided By FDA Letter?
Tickers ICPT NASH NEWS
Tags PBC Analyst Ratings FDA
From Benzinga
Why Shares Of Intercept Pharma Are Soaring Today
Tickers NASH
Tags biotechnology Intercept OCA
From Stocks to Watch
Here's Why Shares Of Intercept Jumped Nearly 10% On Friday
Tickers ICPT NASH NEWS
Tags General Adam Feuerstein Regenerate
From Benzinga
A Primer On NASH
Tickers AGN NASH NVO SHPG
Tags Trading Ideas General AGN
From Benzinga
These are the seven stupidest ETFs on the planet
Tickers AAPL ACHC ATVI DEO
Tags NTDOY NKE GAMR
From MarketWatch
Allergan Going After Gilead? Gabelli Says CEO 'Playing Chess While The Market Is Playing Checkers'
Tickers AGN BIIB GILD NASH
Tags Analyst Color NASH Allergan
From Benzinga
Allergan's Tobira Acquisition Represents The Highest Premium Ever Paid In Biopharma
Tickers AGN GILD NASH NEWS
Tags Benzinga Liver Diseases Biotechnology Acquisitions
From Benzinga
NASH Sympathy Plays On Tobira Therapeutics Deal
Tickers AGN CNAT GALT GILD
Tags NVO CNAT NASH
From Benzinga
Tobira Therapetuics Up 760% Following Allergan Buyout, Liver Drug A Key Focus
Tickers AGN NASH NEWS TBRA
Tags News David Nicholson M&A
From Benzinga
‘Label lexicon’ is yet another problem for investors
Tickers NASH TM
Tags CH:NESN Commodities Financial Services
From MarketWatch
How gold and silver plays have zoomed past all other investments
Tickers AVP CPXX DSW GLD
Tags Transportation CLJ6 Analyst Research/Ratings
From MarketWatch
Morgan Stanley Upgrades Intercept Pharma, Maintains $100 Target
Tickers ICPT NASH
Tags Upgrades FDA NASH
From Benzinga
There's An ETF For That: 10 Oddball Funds
Tickers BJK COW GRN LIT
Tags TSLA SPY BJK
From Benzinga
Roth Still Loves Galmed Pharma, Keeps $20 Price Target And 'Buy' Rating
Tickers GLMD NASH ROTH
Tags Analyst Color NASH Analyst Ratings
From Benzinga
Nomura's Takeaways From Meeting With Gilead Sciences' Management
Tickers GILD NASH
Tags Benzinga GILD Reiteration
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.